Novel Therapies for Hepatocellular Carcinoma

Novel Therapies for Hepatocellular Carcinoma

Since 2007, for patients with advanced- or intermediate-stage hepatocellular carcinoma (HCC) unsuitable for locoregional treatments and with preserved liver function, the multikinase inhibitor (MKI) sorafenib has been the worldwide standard of care [...]

Bibliographic Details
Main Author:	Lorenza Rimassa
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Cancers
Subjects:	n/a
Online Access:	https://www.mdpi.com/2072-6694/12/10/3049

Similar Items

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
by: Nicola Personeni, et al.
Published: (2020-03-01)

Human Hepatocellular Carcinoma (HCC)
by: Luigi Buonaguro
Published: (2020-12-01)

Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
by: Kazushi Numata
Published: (2021-07-01)

Hepatocellular Carcinoma: Special Issue Highlights
by: Medhavi Gupta, et al.
Published: (2020-07-01)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
by: Birke Bartosch
Published: (2010-07-01)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
by: Thomas F. Baumert, et al.
Published: (2019-05-01)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
by: Nicola Personeni, et al.
Published: (2018-06-01)

Erratum: Shibata S.; et al. Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas. <em>Cancers</em> 2018, <em>10</em>, 71
by: Satoshi Shibata, et al.
Published: (2018-12-01)

Drug Resistance and Novel Therapies in Cancers
by: Zhixiang Wang
Published: (2020-10-01)

Novel Targeted Therapies for Advanced Cholangiocarcinoma
by: Alessandro Rizzo, et al.
Published: (2021-02-01)

Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy
by: Elisabetta Palazzo, et al.
Published: (2020-02-01)

Drug Resistance and Novel Therapies in Cancers in 2019
by: Zhixiang Wang
Published: (2021-02-01)

Novel Viral Vector Systems for Gene Therapy
by: Daniel Stone
Published: (2010-04-01)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
by: Ali Abbas Rizvi, et al.
Published: (2021-09-01)

Hong, M. et al. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation. Cells 2019, <i>8</i>, 1466
by: Cells Editorial Office
Published: (2020-07-01)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
by: Personeni N, et al.
Published: (2019-01-01)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
by: Chiun Hsu, et al.
Published: (2021-07-01)

Correction: Wang, M., et al. HSP70–eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma. <i>Cancers</i> 2020, <i>12</i>, 2262
by: Meng Wang, et al.
Published: (2020-11-01)

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective
by: Zlatko Fras, et al.
Published: (2021-09-01)

Correction: Cao, Z., et al. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial—Mesenchymal Transition. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 500
by: Zi Cao, et al.
Published: (2021-12-01)

Comment on: Jilkova, Z.M.; et al. “Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” <i>Cancers</i> 2019, <i>11</i>, 1554
by: Anna Dunnigan
Published: (2020-09-01)

Correction: Liang, J., et al. Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin. Int. J. Mol. Sci. 2012, 13, 10594-10607
by: Bomin Yan, et al.
Published: (2013-03-01)

Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” <i>Cancers</i> 2019, <i>11</i>, 1554
by: Zuzana Macek Jilkova, et al.
Published: (2020-09-01)

Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy
by: Viroj Wiwanitkit
Published: (2013-12-01)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinomaKey points
by: Coskun O. Demirtas, et al.
Published: (2021-10-01)

Correction: Liu, Y.-S.; et al. Inhibition of Protein Phosphatase 1 Stimulates Noncanonical ER Stress eIF2α Activation to Enhance Fisetin-Induced Chemosensitivity in HDAC Inhibitor-Resistant Hepatocellular Carcinoma Cells. <i>Cancers</i> 2019, <i>11</i>, 918
by: Yi-Sheng Liu, et al.
Published: (2020-11-01)

Recent Research on Gastrointestinal Carcinoma
by: Giulia Rovesti, et al.
Published: (2021-01-01)

The Labyrinth of Renal Cell Carcinoma
by: Claudia Manini, et al.
Published: (2020-02-01)

Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma
by: Nanfang Qu, et al.
Published: (2021-10-01)

Erratum: Zheng, L., et al. PBN11-8, a Cytotoxic Polypeptide Purified from Marine <i>Bacillus</i>, Suppresses Invasion and Migration of Human Hepatocellular Carcinoma Cells by Targeting Focal Adhesion Kinase Pathways. <i>Polymers</i> 2018, <i>10</i>, 1043
by: Lanhong Zheng, et al.
Published: (2021-01-01)

Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?
by: Justin B. Wenger, et al.
Published: (2011-09-01)

Phage Therapy, Lysin Therapy, and Antibiotics: A Trio Due to Come
by: Tomás G. Villa, et al.
Published: (2020-09-01)

Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma
by: Leszek Herbowski
Published: (2020-07-01)

Correction: Marino, M.; Misuri, L.; Carati, A.; Brogioli, D. Proof-of-Concept of a Zinc-Silver Battery for the Extraction of Energy from a Concentration Difference. Energies 2014, 7, 3664–3683
by: Massimo Marino, et al.
Published: (2014-08-01)

CAR-T Cell Therapy
by: Aamir Ahmad
Published: (2020-06-01)

Targeting in Cancer Therapies
by: Ramon Mangues, et al.
Published: (2016-03-01)

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
by: D'Alessio A, et al.
Published: (2021-08-01)

Reply to “Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma”
by: Liviu Hitu, et al.
Published: (2020-07-01)

New Insights into the Biological and Clinical Aspects of Merkel Cell Carcinoma
by: Virve Koljonen, et al.
Published: (2021-05-01)

The Role of Adenovirus in Cancer Therapy
by: Mizuho Sato-Dahlman, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_ccga6ve6leebcit4ajpuo8kt81